Pilot evaluation of an optimized context-specific drug-drug interaction alerting system: A controlled pre-post study

被引:28
|
作者
Cornu, Pieter [1 ]
Steurbaut, Stephane [1 ]
Gentens, Kristof [2 ]
Van de Velde, Rudi [2 ]
Dupont, Alain G. [1 ]
机构
[1] Vrije Univ Brussel, Fac Med & Pharm, Res Grp Clin Pharmacol & Clin Pharm KFAR, B-1090 Brussels, Belgium
[2] UZ Brussel, Dept Med Informat, B-1090 Brussels, Belgium
关键词
Pre-postevaluation; Clinical decision support systems; Drug-drug interactions; Hospital; Alert specificity; CLINICAL DECISION-SUPPORT; PHYSICIAN ORDER ENTRY; UNINTENDED CONSEQUENCES; SAFETY ALERTS; STARE-HI; INFORMATION; DISCREPANCIES; PROLONGATION; STATEMENT; PATIENT;
D O I
10.1016/j.ijmedinf.2015.05.005
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objectives: Clinical decision support (CDS) systems are frequently used to reduce unwanted drug-drug interactions (DDIs) but often result in alert fatigue. The main objective of this study was to investigate whether a newly developed context-specific DDI alerting system would improve alert acceptance. Methods: A controlled pre-post intervention study was conducted in 4 departments in a university hospital. After a 7-month pre-intervention period, the new system was activated in the intervention departments, while the old system remained activated in the control departments. Post-intervention data was collected for a 7-month period. Results: A significant increase of the overall acceptance rate was observed between the pre- and post-intervention period (2.2% versus 52.4%; p<0.001) for the intervention departments and between the intervention and control departments (2.5% versus 52.4%; p<0.001) in the post-intervention period. There were no significant differences in acceptance rates between the pre- and post-intervention period in the control departments and also not between the control and intervention departments in the pre-intervention period. Conclusions: The improvement was probably related to several optimization strategies including the customization of the severity classification, the creation of individual screening intervals, the inclusion of context factors for risk assessment, the new alert design and the creation of a follow-up system. The marked increase in alert acceptance looks promising and should be further evaluated after hospital wide implementation. System aspects that require further optimization were identified and will be developed. Further research is warranted to develop context-aware algorithms for complex class-class interactions. Copyright (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:617 / 629
页数:13
相关论文
共 16 条
  • [1] Evaluation of context-specific alerts for potassium-increasing drug-drug interactions: A pre-post study
    Muylle, Katoo M.
    Gentens, Kristof
    Dupont, Alain G.
    Cornu, Pieter
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2020, 133
  • [2] The Effect of Patient-Specific Drug-Drug Interaction Alerting on the Frequency of Alerts: A Pilot Study
    Horn, John
    Ueng, Stephen
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (11) : 1087 - 1092
  • [3] Evaluation of an optimized context-aware clinical decision support system for drug-drug interaction screening
    Muylle, Katoo M.
    Gentens, Kristof
    Dupont, Alain G.
    Cornu, Pieter
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2021, 148
  • [4] Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting
    Duke, Jon D.
    Li, Xiaochun
    Dexter, Paul
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2013, 20 (03) : 494 - 498
  • [5] Data management system for diabetes clinical trials: a pre-post evaluation study
    Aynaz Nourani
    Haleh Ayatollahi
    Masoud Solaymani-Dodaran
    BMC Medical Informatics and Decision Making, 23
  • [6] Data management system for diabetes clinical trials: a pre-post evaluation study
    Nourani, Aynaz
    Ayatollahi, Haleh
    Solaymani-Dodaran, Masoud
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2023, 23 (01)
  • [7] Inhaled loxapine and intramuscular lorazepam in healthy volunteers: a randomized placebo-controlled drug-drug interaction study
    Spyker, Daniel A.
    Cassella, James V.
    Stoltz, Randall R.
    Yeung, Paul P.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (06): : 1 - 8
  • [8] Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study
    Tomida, Takeshi
    Kimura, Takeshi
    Yamamoto, Kazuhiro
    Uda, Atsushi
    Matsumoto, Yuki
    Tamura, Naoki
    Iida, Masashi
    Tanifuji, Akiko
    Matsumoto, Kumiko
    Mizuta, Naomi
    Ebisawa, Kei
    Ohji, Goh
    Omura, Tomohiro
    Iwata, Kentaro
    Yano, Ikuko
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01):
  • [9] Design, development, implementation, and evaluation of a severe drug-drug interaction alert system in the ICU: An analysis of acceptance and override rates
    Karajizadeh, Mehrdad
    Zand, Farid
    Vazin, Afsaneh
    Saeidnia, Hamid Reza
    Lund, Brady D.
    Tummuru, Sai Priya
    Sharifian, Roxana
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2023, 177
  • [10] Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey
    van de Sijpe, Greet
    Quintens, Charlotte
    Walgraeve, Karolien
    Van Laer, Eva
    Penny, Jens
    De Vlieger, Greet
    Schrijvers, Rik
    De Munter, Paul
    Foulon, Veerle
    Casteels, Minne
    van der Linden, Lorenz
    Spriet, Isabel
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2022, 22 (01)